Miragen Therapeutics Inc (NASDAQ:MGEN)

6.88
Delayed Data
As of Jun 22
 +0.10 / +1.47%
Today’s Change
5.01
Today|||52-Week Range
15.91
-34.04%
Year-to-Date
No recent news for Miragen Therapeutics Inc.

Today’s Trading

Previous close6.78
Today’s open6.84
Day’s range6.46 - 6.95
Volume1,279,038
Average volume (3 months)211,821
Market cap$232.8M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+92.14%
Earnings growth (this year)+25.72%
Earnings growth (next 5 years)+7.59%
Revenue growth (last year)+19.96%
P/E ratioNM
Price/Sales50.14
Price/Book4.52

Competitors

 Today’s
change
Today’s
% change
MNOVMediciNova Inc+0.05+0.58%
CRHMCRH Medical Corp+0.05+1.47%
NYMXNymox Pharmaceutical...+0.64+19.69%
MACKMerrimack Pharmaceut...-0.32-3.38%
Data as of 8:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 10, 2018
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$4.0M
Annual profit (last year)-$26.5M
Net profit margin-662.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William S. Marshall
Chief Financial Officer, Secretary &
Treasurer
Jason A. Leverone
Corporate headquarters
Boulder, Colorado

Forecasts